Medindia

X

The Marrow Foundation(R) Hires New President

Monday, August 27, 2007 General News J E 4
Advertisement
MINNEAPOLIS, Aug. 27 The Marrow Foundation, thefundraising arm of the National Marrow Donor Program(R) (NMDP), announcedtoday that Mitch Stoller has joined the organization as president, effectiveimmediately.

(Photo: http://www.newscom.com/cgi-bin/prnh/20070827/AQM003)

As president of The Marrow Foundation, Stoller will be responsible forcreating a culture of philanthropy that supports the programs of the NMDP.The NMDP connects patients, doctors, donors and researchers to the resourcesnecessary to treat leukemia, lymphoma and other life-threatening diseaseswhich can be cured by a marrow or cord blood transplant.

The Marrow Foundation currently raises $5-7 million annually, but hasrecently set a goal to raise $20 million annually by 2012 to meet the growingglobal need for marrow and cord blood transplants. The NMDP manages a Registryof over 6 million volunteers who are willing to donate to any patient in need.On any given day more than 6,000 people search the NMDP Registry for a donor.

"Mitch is a superstar in the world of philanthropy," said NMDP ChiefExecutive Officer Jeffrey W. Chell, M.D. "His proven track record, along withhis excitement and enthusiasm for our mission, will go a long way to helpraise awareness and financial support for the NMDP."

Stoller has more than 26 years of experience in nonprofit management andfundraising. Prior to joining The Marrow Foundation, Stoller served as thepresident and chief executive officer of the Lance Armstrong Foundation, wherehe was responsible for leading one of the fastest growing nonprofitorganizations in the field of cancer survivorship.

Prior to that, Stoller served as the president and chief executive officerof the Christopher Reeve Paralysis Foundation, where he was responsible forincreasing funding from $1.6 million to $16 million and creating the Qualityof Life campaign, a grassroots program that invests more than $2 million inthe disability community.

Earlier in Stoller's career, he served as the executive vice president andchief operating officer of the Sudden Infant Death Syndrome Alliance, where heled the organization through a corporate merger and grew the annual operatingbudget from $450,000 to $1,750,000.

"I'm excited to be joining the NMDP at a time when the organization isexperiencing exponential growth," said Stoller. "I believe in our mission, andI look forward to working closely with Dr. Chell and the NMDP team to impactoutcomes for patients and their families."

Stoller replaces Jill McGovern, who retired in December 2006 after serving14 years as chief executive officer of The Marrow Foundation.

Stoller holds a bachelor's degree in health and physical education fromFrostburg State College in Frostburg, Md., and a master's degree inphilanthropy and development from Saint Mary's University of Minnesota,Winona. He serves on the board of directors of the Lance ArmstrongFoundation, National Health Council, ePhilanthropy Foundation, and the PlayersDevelopment Academy. Stoller is also a previous board member of the CJFoundation for SIDS.

About the National Marrow Donor Program

The NMDP facilitates unrelated marrow and blood cell transplants as asingle point of access for a long-standing collaborative network of nationaland international leading medical facilities in marrow and cord bloodtransplantation. The NMDP connects patients, doctors, donors and researchersto the resources they need to help more people live longer and healthierlives. For more information call 1 (800) MARROW-2 or visithttp://www.marrow.org. Join online at http://www.marrow.org/join.

About the Marrow Foundation

The Marrow Foundation is a nonprofit organization that raises funds andother support from the private sector to support the work of the NationalMarrow Donor Program. The Marrow Foundation helps patients with un
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Corbett Accel Healthcare Group Implements 'Real-Ti...
S
Rubicor Medical, Inc. Receives $10 Million in Fina...